Ricefidase
- Generic Name
- Ricefidase
A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults
- First Posted Date
- 2022-03-10
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT05274659
- Locations
- 🇳🇿
New Zealand Clinical Research, Auckland, New Zealand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath